Hou et al. showed that PD-L1 blockaded therapy could induce cancer cell apoptosis to pyroptosis by mediating gasdermin C expression and facilitating necrosis [37], combined with our results, simultaneously targeting pyroptosis pathways and checkpoint therapy may benefit glioma patients in the high-risk group. Here, GSDMC is linked to central nervous system cancer.